TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy
暂无分享,去创建一个
H. Lenz | S. Okazaki | Dongyun Yang | Wu Zhang | W. Ichikawa | S. Matsusaka | M. Ueno | M. D. Berger | S. Cao | Y. Ning | Y. Sunakawa | D. Hanna | N. Mizunuma | A. Parekh | A. Sebio